On Jan. 2, Hookipa inked a non-binding agreement that would have created a merged company with Poolbeg via an all-stock ...

The wearable cardiac monitor maker VitalConnect has raised $100 million in new capital to aid in the development of its ...

Illumina is raising the curtain on its upcoming entry into spatial transcriptomics, with tech designed to help researchers ...

BioMed X Institute is teaming up with the Barbados government in an effort to accelerate cardiometabolic treatments for ...

UroGen Pharma has opened another front in its attack on bladder cancer, paying IconOVir Bio $4 million in stock for an ...

“Partnering with Genesis Therapeutics presents a unique opportunity to leverage their AI technologies to accelerate the ...

CRISPR-based Spotlight Therapeutics has shut down, former CEO Mary Haak-Frendscho, Ph.D., confirmed with Fierce Biotech. | ...

While the FDA’s diversity guidance for clinical trials has been temporarily restored, the page it is housed on now carries a ...

Clinical trial organization Flourish Research has made a deal with Diablo Clinical Research, acquiring the California-based facility and its expertise in endocrinology, cardiovascular and metabolic ...

Charles River expanded the Memphis facility in November 2022, adding nine processing suites to its 16 clean rooms at the site ...

After privately vying for a change to Dynavax’s corporate strategy for months, life sciences investment firm Deep Track ...

The imaging giant is leasing warehouse space and contracting inventory management through a multiyear deal with logistics ...